These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6423374)
1. Suppressive effect of elcatonin, an eel calcitonin analogue, on excessive urinary hydroxyproline excretion in polyostotic fibrous dysplasia (McCune-Albright's syndrome). Yamamoto K; Maeyama I; Kishimoto H; Morio Y; Harada Y; Ishitobi K; Ishikawa J Endocrinol Jpn; 1983 Oct; 30(5):651-6. PubMed ID: 6423374 [TBL] [Abstract][Full Text] [Related]
2. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia. Bell NH; Avery S; Johnston CC J Clin Endocrinol Metab; 1970 Sep; 31(3):283-90. PubMed ID: 4916538 [No Abstract] [Full Text] [Related]
3. A case of Albright's syndrome treated with calcitonin. Hjelmstedt A; Ljunghall S Acta Orthop Scand; 1979 Jun; 50(3):251-3. PubMed ID: 474095 [TBL] [Abstract][Full Text] [Related]
4. Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: aetiological and therapeutic implications. Long A; Loughlin T; Towers RP; McKenna TJ Ir J Med Sci; 1988 Jul; 157(7):229-34. PubMed ID: 2971632 [No Abstract] [Full Text] [Related]
5. Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin. Azuma Y; Chokki M; Ohta T; Kiyoki M Endocrinology; 1996 Jun; 137(6):2586-92. PubMed ID: 8641213 [TBL] [Abstract][Full Text] [Related]
7. Effects of calcitonin in metastatic bone carcinoma, osteoporosis, polyostotic fibrous dysplasia and hypercalcemia. Morii H; Tanae A; Ibayashi H; Nakao K Endocrinol Jpn; 1971 Feb; 17(6):81-90. PubMed ID: 4254451 [No Abstract] [Full Text] [Related]
8. Accelerated bone turnover in pregnant women with McCune-Albright syndrome. Osada H; Sakamoto R; Seki K; Sekiya S Gynecol Obstet Invest; 2005; 60(2):102-7. PubMed ID: 15860920 [TBL] [Abstract][Full Text] [Related]
14. Albright's syndrome in a four-months-old girl. PANDE H Acta Paediatr (Stockh); 1959 Jul; 48():397-402. PubMed ID: 14430103 [No Abstract] [Full Text] [Related]
15. Metabolic bones diseases in practice. Osteoporosis, Paget's disease, von Recklinghausen's disease, and Albright's syndrome. GORDAN GS Am Pract Dig Treat; 1951 Feb; 2(2):113-9. PubMed ID: 14799735 [No Abstract] [Full Text] [Related]
16. [Polyostotic fibrous dysplasia (Albright's syndrome); review and two case reports]. SKANSE B; LANGELAND P; VON ROSEN S Nord Med; 1956 Jun; 55(24):833-7. PubMed ID: 13348922 [No Abstract] [Full Text] [Related]
17. Endocrine features in Albright's syndrome (fibrous dysplasia of bone). BENEDICT PH Metabolism; 1962 Jan; 11():30-45. PubMed ID: 13867139 [No Abstract] [Full Text] [Related]
18. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins]. Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215 [TBL] [Abstract][Full Text] [Related]
19. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology]. Chapuy MC; Meunier P; Terrier M; David L; Vignon G Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838 [TBL] [Abstract][Full Text] [Related]
20. Polyostotic fibrous dysplasia. (Albright's disease) Report of a case and review of the disease. MINAISY A J Egypt Med Assoc; 1950; 33(8-9):785-90. PubMed ID: 14804606 [No Abstract] [Full Text] [Related] [Next] [New Search]